Vivos Therapeutics, Inc. financial data

Symbol
VVOS on Nasdaq
Industry
Surgical & Medical Instruments & Apparatus
Location
7921 Southpark Plaza,, Suite 210, Littleton, CO
State of incorporation
DE
Fiscal year end
December 31
Former names
Vivos BioTechnologies, Inc. (to 9/29/2017)
Latest financial report
10-K - Q4 2024 - Mar 31, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 106 % +77.1%
Debt-to-equity 158 % -64.2%
Return On Equity -198 % +65.3%
Return On Assets -76.4 % +27%
Operating Margin -74.3 % +40.7%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 5.89M shares +116%
Common Stock, Shares, Outstanding 5.89M shares +221%
Entity Public Float 7.4M USD -51.6%
Common Stock, Value, Issued 3K USD +50%
Weighted Average Number of Shares Outstanding, Basic 5.02M shares +312%
Weighted Average Number of Shares Outstanding, Diluted 5.02M shares +312%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 15M USD +8.91%
Research and Development Expense 100K USD -50%
Selling and Marketing Expense 1.73M USD -29.8%
General and Administrative Expense 17.9M USD -20.5%
Operating Income (Loss) -11.2M USD +35.4%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -11.1M USD +18%
Net Income (Loss) Attributable to Parent -11.1M USD +18%
Earnings Per Share, Basic -2.22 USD/shares +80.1%
Earnings Per Share, Diluted -2.22 USD/shares +80.1%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 6.26M USD +281%
Accounts Receivable, after Allowance for Credit Loss, Current 430K USD +113%
Assets, Current 7.47M USD +204%
Property, Plant and Equipment, Net 3.35M USD +1.09%
Operating Lease, Right-of-Use Asset 1.03M USD -25.5%
Intangible Assets, Net (Excluding Goodwill) 370K USD -11.9%
Goodwill 2.84M USD 0%
Assets 15.3M USD +42.4%
Accounts Payable, Current 1.1M USD -48.8%
Accrued Liabilities, Current 2.23M USD -4.28%
Contract with Customer, Liability, Current 896K USD -58.1%
Liabilities, Current 4.98M USD -31.7%
Long-term Debt and Lease Obligation 1.2M USD 0%
Contract with Customer, Liability, Noncurrent 97K USD -66.4%
Operating Lease, Liability, Noncurrent 1.04M USD -32%
Liabilities 7.33M USD -29%
Retained Earnings (Accumulated Deficit) -104M USD -12%
Stockholders' Equity Attributable to Parent 7.95M USD +1835%
Liabilities and Equity 15.3M USD +42.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.52M USD +28.9%
Net Cash Provided by (Used in) Financing Activities 3.64M USD -50.6%
Net Cash Provided by (Used in) Investing Activities -151K USD +47.8%
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 5.89M shares +221%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 968K USD -72.6%
Deferred Tax Assets, Valuation Allowance 21.5M USD +11.3%
Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent 0.21 pure 0%
Deferred Tax Assets, Gross 21.8M USD +10.7%
Operating Lease, Liability 1.51M USD -24.2%
Depreciation 600K USD 0%
Payments to Acquire Property, Plant, and Equipment 151K USD -36.8%
Lessee, Operating Lease, Liability, to be Paid 1.73M USD -26.8%
Property, Plant and Equipment, Gross 6.21M USD +10.1%
Operating Lease, Liability, Current 477K USD +0.63%
Lessee, Operating Lease, Liability, to be Paid, Year Two 507K USD -14.6%
Lessee, Operating Lease, Liability, to be Paid, Year One 585K USD -5.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 213K USD -40.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 493K USD -2.76%
Deferred Tax Assets, Operating Loss Carryforwards 19.9M USD +14.5%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 50M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 133K USD -73%
Operating Lease, Payments 153K USD
Additional Paid in Capital 112M USD +20%
Preferred Stock, Shares Outstanding 0 shares
Amortization of Intangible Assets 100K USD 0%
Depreciation, Depletion and Amortization 146K USD -16.6%
Deferred Tax Assets, Net of Valuation Allowance 255K USD -25%
Share-based Payment Arrangement, Expense 100K USD -50%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%